Trial Profile
Incidence of major coronary evaginations in Nobori biolimus-eluting biodegradable polymer stent (N-BES) treated patients with non-ST segment elevation myocardial infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Nov 2016
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- 22 Nov 2016 New trial record